by Samantha LaDuc | Apr 17, 2020
This is not a typo. Not kidding: Gilead popped after market hours today on Remdesivir news on a treatment for COVID19. We caught it LIVE in my trading room. Assuming it sticks for the overnight, and it stays at/above $85 it will return 25,000%. I have been bullish...
by Samantha LaDuc | Apr 15, 2020
Don’t Tug On Superman’s Cape April 09, 2020 You can put aside your fancy chart patterns, and your in-depth fundamental analyses. The Fed is now in charge of everything, and the Fed is buying. As the late Martin Zweig advised, “Don’t fight the Fed.” After 10 years of having stimulative interest rate policy, the Fed […]
by Samantha LaDuc | Apr 12, 2020
The Week That Was Last week I anticipated $2800 would be tagged and it was. My range – as posted this weekend – was higher into $2800 but still holding the belief that we would begin to snake sideways from there. Curiously, institutions are already positioned for...
by Jay Reynolds | Apr 10, 2020
This is a new series idea from a colleague of LaDucTrading, Jay Reynolds, who offers up some timely, relevant and personal vignettes on CoronaVirus news that you won’t likely get anywhere else. These posts should be easy to scan and synthesize, with a peppering...
by Samantha LaDuc | Mar 20, 2020
February 27th Client post: I’ve never seen distribution selling under the price action like this in the entirety of my trading career. I smelled/warned/wrote about but had no vision for a flash crash or waterfall just stair-stepping those $SPY gap fills. We are...